{
  "market_share_distribution": {
    "metric": "TRXMktShare4",
    "mean": 92.17,
    "median": 100.0,
    "std": 22.99,
    "min": 0.0,
    "max": 100.0
  },
  "competitive_segments": {
    "IBSA Dominant (>50%)": {
      "count": 54544,
      "percentage": 93.55
    },
    "Unknown": {
      "count": 41694,
      "percentage": 71.51
    },
    "Competitor Dominant (<25%)": {
      "count": 1712,
      "percentage": 2.94
    },
    "Zero IBSA Share": {
      "count": 1489,
      "percentage": 2.55
    },
    "Balanced (25-50%)": {
      "count": 561,
      "percentage": 0.96
    }
  },
  "share_trends": {
    "declining_hcps": 2698,
    "declining_percentage": 2.7,
    "growing_hcps": 3253,
    "growing_percentage": 3.25,
    "stable_hcps": 94049
  },
  "at_risk_hcps": {
    "count": 722,
    "avg_share_loss": -10.29,
    "total_trx_at_risk": 3073
  },
  "opportunity_hcps": {
    "count": 285,
    "avg_current_share": 11.99,
    "total_trx_opportunity": 1702,
    "potential_share_gain": 88.01
  },
  "statistical_tests": {},
  "recommendations": [
    "URGENT: 722 high-value HCPs are losing share - competitive threat!",
    "OPPORTUNITY: 285 high-volume HCPs with <25% IBSA share - growth targets!"
  ]
}